Use of a New Isokinetic Device for Inspiratory Muscle Training
Sponsored by Universidade Federal Fluminense
About this trial
Last updated 4 years ago
Study ID
isokinetic device
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 86 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
Introduction:
It is well established that physical fitness improves muscle performance either in
sedentary people or in athletes. In this regard, specific exercises for respiratory
muscles can result in better functional performance in hospitalized individuals,
especially in critically ill patients in prolonged weaning.
Objectives:
To compare the following variables between intervention and control patients: success in
weaning, free time off ventilator on ICU after weaning, and gain of muscle strength with
the use of the inspiratory muscle training (IMT).
Patients and methods:
Prospective randomized controlled clinical trial. Only individuals on prolonged weaning
will be enrolled. They will undergo IMT or will be managed in a conventional manner. The
primary endpoint will be successful weaning. In addition, other variables such as free
time off ventilator on ICU after weaning and muscle strength will be measured. In
addition, mortality in the ICU, inside the hospital and after discharge will be followed
for one year after study entrance.
Expected results:
According to the working hypothesis, it is expected that the performance of patients
undergoing IMT will be superior to the conventional treatment. Also, their time to
mortality is expected to be longer.
What are the participation requirements?
Inclusion Criteria
- Individuals over the age of 18 on mechanical ventilation
- Able to initiate ventilator weaning.
Exclusion Criteria
- Positive serology for HIV
- Other immunesupressive conditions
- Life expectancy less than 12 months
- Spinal cord injury above T8
- Mechanical ventilation started at another institution
- Body mass index >35 kg/m2.